NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative for Diabetes on Monday announced a €1 billion ($1.2 billion), 10-year project focusing on pancreatic islet cell function and survival.
The project will involve research into developing biomarkers and tools to better manage diabetes with the hope of curing the disease, which affects 285 million people worldwide, IMIDIA said in a statement.